Literature DB >> 18992254

Efficient isolation of soluble intracellular single-chain antibodies using the twin-arginine translocation machinery.

Adam C Fisher1, Matthew P DeLisa.   

Abstract

One of the most commonly used recombinant antibody formats is the single-chain variable fragment (scFv) that consists of the antibody variable heavy chain connected to the variable light chain by a flexible linker. Since disulfide bonds are often necessary for scFv folding, it can be challenging to express scFvs in the reducing environment of the cytosol. Thus, we sought to develop a method for antigen-independent selection of scFvs that are stable in the reducing cytosol of bacteria. To this end, we applied a recently developed genetic selection for protein folding and solubility based on the quality control feature of the Escherichia coli twin-arginine translocation (Tat) pathway. This selection employs a tripartite sandwich fusion of a protein-of-interest with an N-terminal Tat-specific signal peptide and C-terminal TEM1 beta-lactamase, thereby coupling antibiotic resistance with Tat pathway export. Here, we adapted this assay to develop intrabody selection after Tat export (ISELATE), a high-throughput selection strategy for the identification of solubility-enhanced scFv sequences. Using ISELATE for three rounds of laboratory evolution, it was possible to evolve a soluble scFv from an insoluble parental sequence. We show also that ISELATE enables focusing of an scFv library in soluble sequence space before functional screening and thus can be used to increase the likelihood of finding functional intrabodies. Finally, the technique was used to screen a large repertoire of naïve scFvs for clones that conferred significant levels of soluble accumulation. Our results reveal that the Tat quality control mechanism can be harnessed for molecular evolution of scFvs that are soluble in the reducing cytoplasm of E. coli.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992254      PMCID: PMC2612092          DOI: 10.1016/j.jmb.2008.10.051

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  62 in total

1.  High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.

Authors:  Miro Venturi; Claudia Seifert; Carola Hunte
Journal:  J Mol Biol       Date:  2002-01-04       Impact factor: 5.469

2.  Improving protein folding efficiency by directed evolution using the GFP folding reporter.

Authors:  Geoffrey S Waldo
Journal:  Methods Mol Biol       Date:  2003

3.  Proteolytic antibody light chains alter beta-amyloid aggregation and prevent cytotoxicity.

Authors:  Ruitian Liu; Chad McAllister; Yuri Lyubchenko; Michael R Sierks
Journal:  Biochemistry       Date:  2004-08-10       Impact factor: 3.162

4.  Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications.

Authors:  Tong Cao; Boon Chin Heng
Journal:  Ann Clin Lab Sci       Date:  2005       Impact factor: 1.256

5.  The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm.

Authors:  W A Prinz; F Aslund; A Holmgren; J Beckwith
Journal:  J Biol Chem       Date:  1997-06-20       Impact factor: 5.157

6.  Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.

Authors:  J S Huston; D Levinson; M Mudgett-Hunter; M S Tai; J Novotný; M N Margolies; R J Ridge; R E Bruccoleri; E Haber; R Crea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones.

Authors:  R Levy; R Weiss; G Chen; B L Iverson; G Georgiou
Journal:  Protein Expr Purif       Date:  2001-11       Impact factor: 1.650

8.  Targeting of unfolded PhoA to the TAT translocon of Escherichia coli.

Authors:  Silke Richter; Thomas Brüser
Journal:  J Biol Chem       Date:  2005-10-31       Impact factor: 5.157

9.  Conversion of a peroxiredoxin into a disulfide reductase by a triplet repeat expansion.

Authors:  D Ritz; J Lim; C M Reynolds; L B Poole; J Beckwith
Journal:  Science       Date:  2001-10-05       Impact factor: 47.728

10.  Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library.

Authors:  Michael J Feldhaus; Robert W Siegel; Lee K Opresko; James R Coleman; Jane M Weaver Feldhaus; Yik A Yeung; Jennifer R Cochran; Peter Heinzelman; David Colby; Jeffrey Swers; Christilyn Graff; H Steven Wiley; K Dane Wittrup
Journal:  Nat Biotechnol       Date:  2003-01-21       Impact factor: 54.908

View more
  25 in total

1.  A rapid protein folding assay for the bacterial periplasm.

Authors:  Thomas J Mansell; Stephen W Linderman; Adam C Fisher; Matthew P DeLisa
Journal:  Protein Sci       Date:  2010-05       Impact factor: 6.725

Review 2.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

3.  Mining mammalian genomes for folding competent proteins using Tat-dependent genetic selection in Escherichia coli.

Authors:  Hyung-Kwon Lim; Thomas J Mansell; Stephen W Linderman; Adam C Fisher; Michael R Dyson; Matthew P DeLisa
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

Review 4.  A microbial sensor for discovering structural probes of protein misfolding and aggregation.

Authors:  Dujduan Waraho-Zhmayev; Lizeta Gkogka; Ta-Yi Yu; Matthew P DeLisa
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

5.  Optimizing recombinant antibodies for intracellular function using hitchhiker-mediated survival selection.

Authors:  Dujduan Waraho-Zhmayev; Bunyarit Meksiriporn; Alyse D Portnoff; Matthew P DeLisa
Journal:  Protein Eng Des Sel       Date:  2014-09-14       Impact factor: 1.650

6.  Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.

Authors:  Erik Kvam; Michael R Sierks; Charles B Shoemaker; Anne Messer
Journal:  Protein Eng Des Sel       Date:  2010-04-08       Impact factor: 1.650

7.  Engineering antibody fitness and function using membrane-anchored display of correctly folded proteins.

Authors:  Amy J Karlsson; Hyung-Kwon Lim; Hansen Xu; Mark A Rocco; Matthew A Bratkowski; Ailong Ke; Matthew P DeLisa
Journal:  J Mol Biol       Date:  2011-12-16       Impact factor: 5.469

8.  Analysis of the relationship between end-to-end distance and activity of single-chain antibody against colorectal carcinoma.

Authors:  Jianhua Zhang; Shanhong Liu; Zhigang Shang; Li Shi; Jun Yun
Journal:  Theor Biol Med Model       Date:  2012-08-22       Impact factor: 2.432

9.  Visualizing interactions along the Escherichia coli twin-arginine translocation pathway using protein fragment complementation.

Authors:  Jan S Kostecki; Haiming Li; Raymond J Turner; Matthew P DeLisa
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

10.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.